Prostate cancer screening ⭐

prostate-cancer-screening · society: USPSTF · high-yield

← back to Preventive & Ambulatory Medicine

Summary

USPSTF 2018 recommendation on PSA-based screening for prostate cancer in asymptomatic men. For men 55-69, screening is an individualized decision after shared decision-making about benefits and harms (Grade C, upgraded from D in 2012 based on longer ERSPC follow-up showing reduced prostate cancer mortality and metastatic disease, plus increased use of active surveillance). For men ≥70 years, routine PSA screening is not recommended (Grade D).

Current guideline: USPSTF 2018 Prostate Cancer Screening · download Anki sub-deck

Versions